Citations

Showing 10 of 108135 citations.

Serrated lesions and adenomas in colonoscopic surveillance: additive or exponential?
East, James E. , East, James E

Mayo Clinic

Gut | October 7, 2021 | Volume: 71 | Issue: 10 | Pages: 1932-1933

10.1136/gutjnl-2021-325772 | PMID 34620685 Get It

Inclusion body myositis: correlation of clinical outcomes with histopathology, electromyography and laboratory findings
Pinto, Marcus Vinícius , Laughlin, Ruple S. , Mandrekar, Jay , Naddaf, Elie , Pinto, Marcus V , Naddaf, Elie , Klein, Christopher J.

Mayo Clinic

Rheumatology | October 7, 2021 | Volume: 61 | Issue: 6 | Pages: 2504-2511

10.1093/rheumatology/keab754 | PMID 34617994 Get It

Abstract Objective To determine whether histopathological, electromyographic and laboratory markers correlate with clinical measures in inclusion body myositis (IBM). Methods We reviewed our electronic medical records to identify patients with IBM according to European Neuromuscular Center (ENMC) 2011 criteria, seen between 2015 and 2020. We only included patients who had a muscle biopsy and needle electromyography (EMG) performed on the same muscle (opposite or same side). We used a detailed grading system [0 (normal) to 4 (severe)] to score histopathological and EMG findings. Clinical severity was assessed by the modified Rankin scale (mRS), muscle strength sum score (SSS), quadriceps strength and severity of dysphagia on swallow evaluation. Serum markers of interest were creatine kinase level and cN-1A antibodies. Results We included 50 IBM patients, with a median age of 69 years; 64% were males. Median disease duration at diagnosis was 51 months. On muscle biopsy, endomysial inflammation mainly correlated with dysphagia, and inversely correlated with mRS. Vacuoles and congophilic inclusions did not correlate with any of the clinical measures. On EMG, the shortness of motor un it potential (MUP) duration correlated with all clinical measures. Myotonic discharges, and not fibrillation potentials, correlated with the severity of inflammation. Serum markers did not have a statistically significant correlation with any of the clinical measures. Conclusions Dysphagia was the main clinical feature of IBM correlating with endomysial inflammation. Otherwise, inclusion body myositis clinical measures had limited correlation with histopathological features in this study. The shortness of MUP duration correlated with all clinical measures.
Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitis
Berti, Alvise , Hillion, Sophie , Hummel, Amber M., Son, Young Min , Chriti, Nedra, Peikert, Tobias, Carmona, Eva M. , Abdulahad, Wayel H. , Heeringa, Peter , Harris, Kristina M. , Clair, E. William St. , Brunetta, Paul , Langford, Carol A. , Kallenberg, Cees G. M., Stone, John H. , Grandi, Guido , Cornec, Divi, Carmona, Eva M , Berti, Alvise , Fervenza, Fernando C. , Merkel, Peter A. , Monach, Paul A. , Seo, Philip , Spiera, Robert , Sun, Jie , Pers, Jacques-Olivier , Specks, Ulrich , Cornec, Divi

Mayo Clinic

JCI Insight | October 7, 2021 | Volume: 6 | Issue: 22 | Pages: No page available

10.1172/jci.insight.150999 | PMID 34618687 Get It

BACKGROUND Little is known about the autoreactive B cells in antineutrophil cytoplasmic antibody–associated (ANCA-associated) vasculitis (AAV). We aimed to investigate tolerance checkpoints of circulating antigen-specific proteinase 3–reactive (PR3 + ) B cells. METHODS Multicolor flow cytometry in combination with bioinformatics and functional in vitro studies were performed on baseline samples of PBMCs from 154 well-characterized participants of the RAVE trial (NCT00104299) with severely active PR3-AAV and myeloperoxidase-AAV (MPO-AAV) and 27 healthy controls (HCs). Clinical data and outcomes from the trial were correlated with PR3 + B cells (total and subsets). RESULTS The frequency of PR3 + B cells among circulating B cells was higher in participants with PR3-AAV (4.77% median [IQR, 3.98%–6.01%]) than in participants with MPO-AAV (3.16% median [IQR, 2.51%–5.22%]) and participants with AAV compared with HCs (1.67% median [IQR, 1.27%–2.16%], P < 0.001 for all comparisons), implying a defective central tolerance checkpoint in patients with AAV. Only PBMCs from participants with PR3-AAV contained PR3 + B cells capable of secreting PR3-ANCA IgG in vitro, proving they were functionally distinct from those of participants with MPO-AAV and HCs. Unsupervised clustering identified subtle subsets of atypical autoreactive PR3 + memory B cells accumulating through the maturation process in patients with PR3-AAV. PR3 + B cells were enriched in the memory B cell compartment of participants with PR3-AAV and were associated with higher serum CXCL13 levels, suggesting an increased germinal center activity. PR3 + B cells correlated with systemic inflammation (C-reactive protein and erythrocyte sedimentation rate, P < 0.05) and complete remission ( P < 0.001). CONCLUSION This study suggests the presence of defective central antigen-independent and peripheral antigen-dependent checkpoints in patients with PR3-AAV, elucidating the selection process of autoreactive B cells. Trial registration ClinicalTrials.gov NCT00104299. Funding The Vasculitis Foundation, the National Institute of Allergy and Infectious Diseases of the NIH, and the Mayo Foundation for Education and Research.
Management of a Primary Retroperitoneal Yolk Sac Tumor
Shoukry, Mira , Kaplan, Jamie L. , Mangum, Catherine, Bagaria, Sanjay P. , Gabriel, Emmanuel , Mangum, Catherine A, Gabriel, Emmanuel M

Mayo Clinic

American Journal of Case Reports | October 7, 2021 | Volume: 22 | Issue: No issue available | Pages: No page available

10.12659/ajcr.933258 | PMID 34705815 Get It

Procainamide pharmacokinetics during extracorporeal membrane oxygenation
Vollmer, Nicholas , Wittwer, Erica D. , Rosenbaum, Andrew , Wieruszewski, Patrick M. , Vollmer, Nicholas J , Rosenbaum, Andrew N , Wieruszewski, Patrick M

Mayo Clinic

Perfusion | October 7, 2021 | Volume: 38 | Issue: 2 | Pages: 409-413

10.1177/02676591211050606 | PMID 34617854 Get It

Procainamide is a useful agent for management of ventricular arrhythmia, however its disposition and appropriate dosing during extracorporeal membrane oxygenation (ECMO) is unknown. We report experience with continuous procainamide infusion in a critically ill adult requiring venoarterial ECMO for incessant ventricular tachycardia. Pharmacokinetic analysis of procainamide and its metabolite, N-acetylprocainamide (NAPA), was performed using serum and urine specimens. Kidney function was preserved, and sequencing of the N-acetyltransferase 2 gene revealed the patient was a phenotypic slow acetylator. Procainamide volume of distribution and half-life were calculated and found to be similar to healthy individuals. However, despite elevated serum procainamide concentrations, NAPA concentrations remained far lower in the serum and urine. The magnitude of procainamide and NAPA discordance suggested alternative contributors to the deranged pharmacokinetic profile, and we hypothesized NAPA sequestration by the ECMO circuit. Ultimately, the patient received orthotopic cardiac transplantation and was discharged home in stable condition. Procainamide should be used cautiously during ECMO, with close therapeutic drug monitoring of serum procainamide and NAPA concentrations. The achievement of therapeutic NAPA concentrations while maintaining safe serum procainamide concentrations during ECMO support may be challenging.
Masks, Empathy, and a Pediatric Cancer Diagnosis During COVID-19
McCarthy, Sarah , Schiltz, Brenda , McCarthy, Sarah R. , McCarthy, Sarah R Brand, McCarthy, Sarah R , McCarthy, Sarah R.

Mayo Clinic

Pediatrics | October 7, 2021 | Volume: 148 | Issue: 5 | Pages: No page available

10.1542/peds.2021-051696 | PMID 34620726 Get It

A Stepwise Approach to the “Frozen Neck” for Secondary Microsurgical Reconstruction
Chicco, Maria , Huang, Tony Chieh‐Ting , Lee, Min‐Min , Cheng, Hsu-Tang

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | October 7, 2021 | Volume: 9 | Issue: 10 | Pages: e3841

10.1097/gox.0000000000003841 | PMID 34616642 Get It

Definitive Diagnostic Evaluation of the Child With Arterial Ischemic Stroke and Approaches to Secondary Stroke Prevention
Lee, Sarah , Wasserman, Bruce A. , Heit, Jeremy J. , Negrotto, Matías , Abruzzo, Todd , Abruzzo, Todd A, Heit, Jeremy J , Muthusami, Prakash , Chandra, Ronil Vikesh , Hui, Ferdinand

Mayo Clinic

Topics in Magnetic Resonance Imaging | October 7, 2021 | Volume: 30 | Issue: 5 | Pages: 225-230

10.1097/rmr.0000000000000272 | PMID 34613945 Get It

Abstract In children with arterial ischemic stroke (AIS), the definitive diagnosis of stroke subtype and confirmation of stroke etiology is necessary to mitigate stroke morbidity and prevent recurrent stroke. The common causes of AIS in children are sharply differentiated from the common causes of adult AIS. A comprehensive, structured diagnostic approach will identify the etiology of stroke in most children. Adequate diagnostic evaluation relies on advanced brain imaging and vascular imaging studies. A variety of medical and surgical secondary stroke prevention strategies directed at the underlying cause of stroke are available. This review aims to outline strategies for definitive diagnosis and secondary stroke prevention in children with AIS, emphasizing the critical role of neuroimaging.
Initial Diagnostic Evaluation of the Child With Suspected Arterial Ischemic Stroke
Negrotto, Matías , Wasserman, Bruce A. , Lee, Sarah , Heit, Jeremy J. , Abruzzo, Todd , Abruzzo, Todd A, Heit, Jeremy J , Muthusami, Prakash , Chandra, Ronil Vikesh , Hui, Ferdinand

Mayo Clinic

Topics in Magnetic Resonance Imaging | October 7, 2021 | Volume: 30 | Issue: 5 | Pages: 211-223

10.1097/rmr.0000000000000276 | PMID 34613944 Get It

Abstract Numerous factors make the initial diagnostic evaluation of children with suspected arterial ischemic stroke (AIS) a relatively unsettling challenge, even for the experienced stroke specialist. The low frequency of pediatric AIS, diversity of unique age-oriented stroke phenotypes, and unconventional approaches required for diagnosis and treatment all contribute difficulty to the process. This review aims to outline important features that differentiate pediatric AIS from adult AIS and provide practical strategies that will assist the stroke specialist with diagnostic decision making in the initial phase of care.
Reperfusion Therapies for Children With Arterial Ischemic Stroke
Heit, Jeremy J. , Negrotto, Matías , Lee, Sarah , Wasserman, Bruce A. , Abruzzo, Todd , Abruzzo, Todd A, Heit, Jeremy J , Muthusami, Prakash , Chandra, Ronil Vikesh , Hui, Ferdinand

Mayo Clinic

Topics in Magnetic Resonance Imaging | October 7, 2021 | Volume: 30 | Issue: 5 | Pages: 231-243

10.1097/rmr.0000000000000273 | PMID 34613946 Get It

Abstract Modern hyperacute reperfusion therapies including intravenous thrombolysis and mechanical thrombectomy have transformed the management of arterial ischemic stroke (AIS) in adults. Multiple randomized clinical trials have demonstrated that these therapies enable remarkable improvements in clinical outcome for properly selected patients with AIS. Because pediatric patients were excluded from predicate clinical trials, there is a conspicuous lack of data to guide selection of therapies and inform age-adjusted and pathology-oriented treatment modifications for children. Specifically, technical guidance concerning treatment eligibility, drug dosing, and device implementation is lacking. This review aims to outline important features that differentiate pediatric AIS from adult AIS and provide practical strategies that will assist the stroke specialist with therapeutic decision making.